DK1410019T3 - Assay for kardiovaskulær sikkerhed - Google Patents
Assay for kardiovaskulær sikkerhedInfo
- Publication number
- DK1410019T3 DK1410019T3 DK02762316T DK02762316T DK1410019T3 DK 1410019 T3 DK1410019 T3 DK 1410019T3 DK 02762316 T DK02762316 T DK 02762316T DK 02762316 T DK02762316 T DK 02762316T DK 1410019 T3 DK1410019 T3 DK 1410019T3
- Authority
- DK
- Denmark
- Prior art keywords
- cardiovascular safety
- kits
- safety assay
- cardiotoxicity
- assays
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Sampling And Sample Adjustment (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01202689 | 2001-07-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1410019T3 true DK1410019T3 (da) | 2006-03-06 |
Family
ID=8180635
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02762316T DK1410019T3 (da) | 2001-07-13 | 2002-07-02 | Assay for kardiovaskulær sikkerhed |
Country Status (14)
Country | Link |
---|---|
US (3) | US20040161805A1 (da) |
EP (1) | EP1410019B1 (da) |
JP (1) | JP4570870B2 (da) |
CN (1) | CN1276254C (da) |
AT (1) | ATE308046T1 (da) |
AU (1) | AU2002328312B8 (da) |
CA (1) | CA2450581C (da) |
DE (1) | DE60206923T2 (da) |
DK (1) | DK1410019T3 (da) |
ES (1) | ES2252505T3 (da) |
HK (1) | HK1070693A1 (da) |
IL (2) | IL159819A0 (da) |
NZ (1) | NZ529496A (da) |
WO (1) | WO2003006988A1 (da) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0302775D0 (sv) * | 2003-10-20 | 2003-10-20 | Astrazeneca Ab | Chemical compound and assay |
US7396524B2 (en) * | 2005-08-02 | 2008-07-08 | Main Line Health Heart Center | Methods for screening compounds for proarrhythmic risk and antiarrhythmic efficacy |
US9820888B2 (en) | 2006-09-26 | 2017-11-21 | Smith & Nephew, Inc. | Wound dressing |
GB0902368D0 (en) | 2009-02-13 | 2009-04-01 | Smith & Nephew | Wound packing |
WO2012106590A2 (en) | 2011-02-04 | 2012-08-09 | University Of Massachusetts | Negative pressure wound closure device |
US9421132B2 (en) | 2011-02-04 | 2016-08-23 | University Of Massachusetts | Negative pressure wound closure device |
CN104661601B (zh) | 2012-05-22 | 2018-06-22 | 史密夫及内修公开有限公司 | 用于伤口治疗的设备和方法 |
MX2014014265A (es) | 2012-05-22 | 2015-06-23 | Smith & Nephew | Dispositivo para cierre de heridas. |
WO2013175309A1 (en) | 2012-05-24 | 2013-11-28 | Smith & Nephew Plc | Devices and methods for treating and closing wounds with negative pressure |
US9962295B2 (en) | 2012-07-16 | 2018-05-08 | Smith & Nephew, Inc. | Negative pressure wound closure device |
AU2014248519B2 (en) | 2013-03-13 | 2018-12-20 | Smith & Nephew Inc. | Negative pressure wound closure device and systems and methods of use in treating wounds with negative pressure |
US10159771B2 (en) | 2013-03-14 | 2018-12-25 | Smith & Nephew Plc | Compressible wound fillers and systems and methods of use in treating wounds with negative pressure |
EP3288509B1 (en) | 2015-04-29 | 2022-06-29 | Smith & Nephew, Inc | Negative pressure wound closure device |
US10575991B2 (en) | 2015-12-15 | 2020-03-03 | University Of Massachusetts | Negative pressure wound closure devices and methods |
US10814049B2 (en) | 2015-12-15 | 2020-10-27 | University Of Massachusetts | Negative pressure wound closure devices and methods |
JP6940920B2 (ja) * | 2017-02-04 | 2021-09-29 | アナバイオス コーポレーション | 医薬誘発性の変力作用および不整脈誘発のリスクを予測するためのシステムおよび方法 |
WO2020124038A1 (en) | 2018-12-13 | 2020-06-18 | University Of Massachusetts | Negative pressure wound closure devices and methods |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4568649A (en) | 1983-02-22 | 1986-02-04 | Immunex Corporation | Immediate ligand detection assay |
WO2000070079A1 (en) * | 1999-05-13 | 2000-11-23 | Ortho-Mcneil Pharmaceutical, Inc. | High throughput assay for modulators of nuclear receptors |
WO2002042735A2 (en) * | 2000-10-30 | 2002-05-30 | Vanderbuilt University | Human kcr1 regulation of herg potassium channel block |
-
2002
- 2002-07-02 AU AU2002328312A patent/AU2002328312B8/en not_active Ceased
- 2002-07-02 DE DE60206923T patent/DE60206923T2/de not_active Expired - Lifetime
- 2002-07-02 DK DK02762316T patent/DK1410019T3/da active
- 2002-07-02 AT AT02762316T patent/ATE308046T1/de not_active IP Right Cessation
- 2002-07-02 NZ NZ529496A patent/NZ529496A/en not_active IP Right Cessation
- 2002-07-02 IL IL15981902A patent/IL159819A0/xx unknown
- 2002-07-02 CA CA2450581A patent/CA2450581C/en not_active Expired - Lifetime
- 2002-07-02 CN CNB02813995XA patent/CN1276254C/zh not_active Expired - Fee Related
- 2002-07-02 ES ES02762316T patent/ES2252505T3/es not_active Expired - Lifetime
- 2002-07-02 US US10/483,617 patent/US20040161805A1/en not_active Abandoned
- 2002-07-02 WO PCT/EP2002/007364 patent/WO2003006988A1/en active IP Right Grant
- 2002-07-02 JP JP2003512705A patent/JP4570870B2/ja not_active Expired - Fee Related
- 2002-07-02 EP EP02762316A patent/EP1410019B1/en not_active Expired - Lifetime
-
2004
- 2004-01-12 IL IL159819A patent/IL159819A/en active IP Right Grant
-
2005
- 2005-04-19 HK HK05103346A patent/HK1070693A1/xx not_active IP Right Cessation
-
2006
- 2006-11-06 US US11/593,399 patent/US7820453B2/en not_active Expired - Fee Related
-
2010
- 2010-08-20 US US12/860,387 patent/US20110076696A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
HK1070693A1 (en) | 2005-06-24 |
WO2003006988A1 (en) | 2003-01-23 |
AU2002328312B8 (en) | 2007-02-15 |
US20110076696A1 (en) | 2011-03-31 |
CN1276254C (zh) | 2006-09-20 |
CN1541334A (zh) | 2004-10-27 |
ES2252505T3 (es) | 2006-05-16 |
EP1410019A1 (en) | 2004-04-21 |
US20080193924A1 (en) | 2008-08-14 |
AU2002328312B2 (en) | 2006-12-14 |
US7820453B2 (en) | 2010-10-26 |
CA2450581C (en) | 2010-11-02 |
IL159819A0 (en) | 2004-06-20 |
IL159819A (en) | 2010-05-31 |
CA2450581A1 (en) | 2003-01-23 |
JP2005501037A (ja) | 2005-01-13 |
DE60206923D1 (de) | 2005-12-01 |
ATE308046T1 (de) | 2005-11-15 |
JP4570870B2 (ja) | 2010-10-27 |
NZ529496A (en) | 2005-09-30 |
US20040161805A1 (en) | 2004-08-19 |
AU2002328312A1 (en) | 2003-01-29 |
EP1410019B1 (en) | 2005-10-26 |
DE60206923T2 (de) | 2006-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1070693A1 (en) | Assays and kits for the screening of test compounds | |
WO2007035633A3 (en) | Screening assays and methods | |
ATE515702T1 (de) | Verfahren, mixturen, kits und zusammensetzungen bezüglich der analytbestimmung | |
NO20081374L (no) | Analyser og fremgangsmater som benytter biomarkorer | |
DK0820522T3 (da) | Assays og indretninger til detektering af ekstrahepatisk galdeatresi | |
DE602005015559D1 (de) | Pharmakodynamische tests mit durchflusszytometrie | |
DK1540010T3 (da) | Anvendelse af biomarkører til påvisning af ovariecancer | |
AU2003293704A8 (en) | Methods and kits for assays of rapid screening of diabetes | |
DK1071809T3 (da) | Multiparameter FACS test til påvisning af ændringer i cellulære parametre | |
ES2138628T3 (es) | Metodo para la determinacion inmunologica de un componente de una muestra. | |
ATE351921T1 (de) | Verfahren für fluoreszenzerkennungstest | |
WO2006088700A3 (en) | Human ring specific bnp antibodies | |
MX2009006205A (es) | Inmunoensayo de multiples analitos. | |
DK1858921T3 (da) | Fotoproteiner med forbedret bioluminescens og anvendelse af disse som intracellulære calciumindikatorer | |
MX2009013009A (es) | Inmunoensayos de alta sensibilidad y kits para la determinacion de peptidos y proteinas de interes biologico. | |
DE60325107D1 (de) | Verfahren und kit zum quantitativen und/oder qualitativen nachweis von komponenten in einer probe | |
DE602006014120D1 (de) | Kolloidale metallkonjugate | |
BR0212265B1 (pt) | Método para a determinação de pelo menos três analitos, composição, kit para a determinação de pelo menos três analitos e uso de pelo menos três parceiros de ligação para a determinação de pelo menos três analitos em uma amostra | |
BR0215853A (pt) | Testes de bioequivalência para formulações contendo ferro | |
DK0902286T3 (da) | Immunanalyse med anvendelse af to inkubationer med mærket antigen | |
FR2853077B1 (fr) | Procedes immunochromatographiques en phase solide | |
DE60329861D1 (de) | Neue, auf der antigen-antikörper-reaktion beruhende sondenplatte sowie reagenzienkit und verfahren mit verwendung der sondenplatte | |
BR0314166A (pt) | Teste de hcv | |
SE0301058D0 (sv) | Method and kit for cell analyte assay | |
AU2003242106A8 (en) | Detection kit, assay plate to be used therein, detection method, evaluation method, polyclonal antibody of frog vitellogenin and procss for producing the same |